Salivary, mammary and prostate glands are sex hormone-dependent organs sharing common aspects in structure, hormonal responsiveness and tumor histopathology. Salivary tumors (especially the malignant types) are not as frequent as mammary and prostate neoplasias. Hence, prognosis of some salivary tumors is not always efficient. Here, we review the oncology of salivary gland and its putative relation to breast/prostate tumors.
Background:
Salivary glands comprise a group of minor and major glands lining the oral cavity and they secrete saliva. Saliva is a complex fluid like plasma reflecting in organic constituents. It is of use for the diagnosis and prognosis of certain diseases. [1, 2] Salivary glands share similar characteristics (morphology, sex hormone dependency, cellular mechanisms, and tumor histopathology) to breast and prostate. [3-8] Mammary and prostate tumors are among the most frequent in women and in men, respectively. Salivary tumors correspond to only 3% of all the neoplasms depending on the geographical prevalence unlike frequently seen mammary and prostrate cancers. [9] Malignant salivary tumors are infrequent and a good prognosis is not always available. Here, we review the association of salivary tumors with mammary and prostate neoplasias.
Relating salivary tumors with breast and prostate neoplasias:
Some authors showed that salivary gland tumors may be associated with other neoplasias, mainly breast and prostate tumors. This is especially referred to the increased number of second primary tumors. [3,7] Evidences, although scarce, are discussed below.
Second primary tumors:
In humans, salivary glands are an elective site for second primary tumors of breast and prostate neoplasias. Polyoma virus inoculation appeared to induce salivary tumors in 70% and 30% of male and female mice, respectively. Testosterone treatment increased the tumor frequency in 69-90% of male mice. Nonetheless, orchidectomy (surgical removal of testicles) reduced it to 50%. Oophorectomy (surgical removal of ovaries) as well as estrogen treatment had no effect on salivary gland tumor frequency in females. However, estrogen treatment was associated with breast second primary tumors in 60% of female animals bearing salivary gland tumors.
[31]
Conclusion:
Tumors of salivary glands share very similar histopathological characteristics with breast and prostate neoplasias. They are also influenced by sex hormones. In addition, salivary glands seem to be an elective site for second primary tumors and metastatic lesions of breast and prostate, proposing that these neoplasias are associated with each other in tumorigenesis. Since the mechanism is not known, information leading to association will help in the diagnosis and prognosis of these related cancers.
